Table 1.

FcγRIIa and FcγRIIIa polymorphisms in the study population by treatment arm

CAPOXCAPOX-C
FcγR polymorphismn (%)n (%)
FcγRIIa
 HH14 (25.9)11 (21.6)
 HR27 (50.0)25 (49.0)
 RR13 (24.1)15 (29.4)
FcγRIIIa
 FF22 (40.7)22 (43.1)
 VF24 (44.4)24 (47.1)
 VV8 (14.8)5 (9.8)
FcγRIIa/FcγRIIIa
 HH and/or VV17 (31.5)14 (27.5)
 R and F37 (68.5)37 (72.5)